Sept 24 (Reuters) - Pharmacy middlemen are working on a
proposal to change some of their business practices to avoid new
regulation from the Trump administration, Bloomberg News
reported on Wednesday, citing people familiar with the
discussions.
(Reporting by Siddhi Mahatole in Bengaluru)